P1.01-052 Patient-Reported Outcomes (PROs) in OAK: A Phase III Study of Atezolizumab vs Docetaxel in Non-Small-Cell Lung Cancer (NSCLC)

Details

Language :

English

ISSN :

15560864 and 15561380

Volume :

12

Issue :

11, Number 11 Supplement 2

Database :

Supplemental Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Periodical

Accession number :

ejs43844259

Full Text :

https://doi.org/10.1016/j.jtho.2017.09.706